Cardiovascular Diseases

Finerenone Reduced CV Events and CKD Progression

A randomized, double-blind, placebo-controlled trial in chronic kidney disease (CKD) and type 2 diabetes (T2D) concluded that treatment with finerenone reduced risks of CKD progression and cardiovascular (CV) events. Between September 2015 and June 2018, 5734 patients with CKD and T2D were randomly assigned in a 1:1 ratio to receive finerenone (a nonsteroidal, selective mineralocorticoid receptor antagonist) or placebo. Compared to placebo, finerenone reduced the risk of the composite CKD (kidney failure, a sustained decrease of at least 40% in the eGFR from baseline, or death from renal causes, hazard ratio 0.82), and CV (CV death, myocardial infarction, stroke, or hospitalization for heart failure, hazard ratio 0.86) outcomes over a median follow-up of 2.6 years. Overall, the frequency of adverse events was similar in the two groups, although the incidence of hyperkalemia-related discontinuation of the trial regimen was higher with finerenone than with placebo (2.3% and 0.9%, respectively). The findings support finerenone to be a meaningful treatment option for patients with CKD and T2D, in addition to control of hypertension and hyperglycemia, a renin–angiotensin system blocker and, more recently, a sodium–glucose cotransporter 2 inhibitor. Source: https://www.nejm.org/; https://www.ahajournals.org/

hyangiu

Recent Posts

Mediterranean Diet May Slow Atherosclerosis Progression and Prevent CHD

A Spanish secondary prevention study suggested that Mediterranean diet might reduce neutrophil levels and slow…

4 days ago

2024 Strategies and Criteria for the Diagnosis and Management of Myocarditis

Top 10 key takeaway points of the report of the American College of Cardiology Solution…

2 weeks ago

Irregular Sleep Linked to Higher CVD Risk

A UK device-based prospective study suggested that irregular sleep was associated with higher risk of…

4 weeks ago

Intensive BP Control Benefits T2D Patients

A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events…

1 month ago

Early-Life Sugar Restriction Protective on T2D and High Blood Pressure

A study comparing UK adults conceived just before or after sugar rationing ended found that…

1 month ago

Cold Weather Linked to Higher MI Risk

A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…

2 months ago

This website uses cookies.